Posts by: admin

News

Genomic Health, Inc. has announced that results from nine studies of Oncotype DX® in prostate, breast, and renal cancers will be presented at the European Society for Medical Oncology (ESMO) 2014 ... Read more

September 15, 2014September 15, 2014

Metastatic Castration-Resistant Prostate Cancer Gets New Therapy, As FDA Approves XTANDI

News

Astellas Pharma Inc. and Medivation, Inc. have announced that the U.S. Food and Drug Administration (FDA) approved a new indication for the use of XTANDI® (enzalutamide) capsules to treat patients with ... Read more

September 15, 2014September 16, 2014

Study identifies New Genetic Variants Involved in Prostate Cancer Risk

News

In a new study entitled “A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer” and published in the journal Nature Genetics, an international group of researchers ... Read more

September 12, 2014September 12, 2014

New Guidelines to Treat Advanced Prostate Cancer

News

The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) have published a joint clinical practice guideline on treating men with metastatic castration-resistant prostate cancer (CRPC). The study ... Read more

September 11, 2014September 11, 2014

GenSpera Receives Key Patent on Prodrug for Prostate Cancer

News

GenSpera, Inc., a leader in developing prodrug therapeutics for the treatment of cancer, has announced that the United States Patent and Trademark Office (USPTO) issued the patent “Tumor Activated Prodrugs” ... Read more

September 10, 2014September 10, 2014

Cometriq Fails to Meet Primary Endpoint in Metastatic Castration-Resistant Prostate Cancer

News

Exelixis, Inc. has announced the results from its COMET-1 phase 3 trial on cabozantinib for the treatment of metastatic castration-resistant prostate cancer (mCRPC) did not meet the primary endpoint of overall ... Read more

September 9, 2014September 9, 2014

Version 2.0 of Prostate Cancer Risk Calculator Online

News

A new study entitled “Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making” and published in the Journal of the American Medical Association, ... Read more

September 8, 2014September 8, 2014

New Promising Prostate Cancer Drug Profiled

News

A new drug candidate to treat challenging cases of prostate cancer, galeterone (VN/124-1), has provided strong preliminary results in clinical trials, leading the U.S. Food and Drug Administration (FDA) to ... Read more

September 4, 2014November 18, 2016

Generex AE37 Prostate Cancer Vaccine Part of Recent Study

News

Generex Biotechnology Corporation, a company focused on the research and development of drug delivery systems and technologies, has announced a follow-up study from its Phase I clinical trial of the ... Read more

September 3, 2014September 5, 2014

BRCA2 Mutations Associated With Poor Prognosis in Prostate Cancer

News

According to a recent study entitled “The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer” and published in the British Journal of Cancer, men with a BRCA2 ... Read more